Alastair Reith


Alastair D. Reith is Senior Scientific Director, Novel Human Genetics Research Unit, GlaxoSmithKline Pharmaceuticals R&D. Dr. Reith has over 30 years’ experience in kinase signalling drug discovery & signalling research – gained in pharmaceutical industry, charitable, and academic research sectors in UK, China and North America.

Alastair has extensive experience in leading drug discovery & development programs for neurodegenerative diseases and forging a network of successful long-term external alliances with academic collaborators, platform technology partners and not-for-profit organisations that has yielded scientific breakthroughs to enable & expedite identification of clinical candidate compounds and their progression to clinical trials.

He has also served on both Institute and grant review panels for BBSRC, as well as review panels & expert advisory groups for a range of Research funding organisations in the charitable sector and UK Research Excellence Framework. Prior to joining GSK, he was a NATO postdoctoral fellow at Mount Sinai Hospital, Toronto, and Assistant Member at Ludwig Institute, University College London. Alastair received his PhD (Biochemistry) from Imperial College London.


Fill in the form and will be in touch with you shortly.

Google reCaptcha: Invalid site key.

Why a form?
Your message is important to us so thank you for filling in our form – it will be received by the intended recipient and you will receive a reply via email. We’ve introduced a form to better protect our team from website scraping generated spam but hope that real people with real messages will still take the time to complete it.